Trinity Care Solutions Recalls Levofloxacin Due to Sterility Concerns
Trinity Care Solutions is recalling 7 units of compounded Levofloxacin 750 mg/250 mL D5W in Florida due to quality control concerns regarding sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall involves a lack of assurance of sterility in a parenteral (intravenous) medication, which poses a significant risk of serious injury or death from infection, meeting the criteria for a Severe rating.
Plain-English summary
Trinity Care Solutions, operating as Franck's Lab Inc, is recalling 7 units of Levofloxacin 750 mg/250 mL D5W. The product is a prescription medication intended for parenteral use only, with a discard date of 05/28/14. The recall is limited to the state of Florida.
The recall was initiated due to a lack of assurance of sterility. This action follows concerns associated with quality control procedures observed during a recent FDA inspection. The agency has classified this recall as Class II.
Patients who have received this specific medication should contact their healthcare provider or pharmacist for guidance on alternative treatment options. The recall applies to all lots of sterile products compounded by the pharmacy within their expiry dates.
The recalled product
- Product
- Levofloxacin 750 mg/250 mL D5W, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx #29184, Discard After 05/28/14
- Manufacturer
- Franck's Lab Inc dba Trinity Care Solutions
- Affected units
- 7
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Rx 29184 Exp 5/28/14
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 30 recalled by Franck's Lab Inc dba Trinity Care Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Franck's Lab Inc dba Trinity Care Solutions
See all →- SevereTrinity Care Solutions Recalls ANA Kit Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Compounded Cubicin Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Desferal Sterile Compounds Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Compounded Cubicin Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Unasyn Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereFranck's Lab Recalls Sterile Levofloxacin Injectable Due to Sterility Concerns
FDA (Drugs) · 2012-08-22
- HighPharm D Solutions Recalls Levocarnitine Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereClaris Lifesciences Recalls Levofloxacin Injection Due to Sterility Concerns
FDA (Drugs) · 2017-04-05
- SevereAltaire Recalls Ofloxacin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereFranck's Lab Recalls Lidocaine/Tetracaine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2012-08-22
- HighPharm D Solutions Recalls Tri-Mix XL Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07